Cargando…

Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery

BACKGROUND: Joint preservation is usually attempted in cases of bone tumors, though insufficient bone following tumour resection may prevent fixation of conventional joint sparing prosthesis. To preserve the hip joint in skeletally immature patients, we have combined autologous proximal femoral irra...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijayan, Sridhar, Bartlett, William, Lee, Robert, Ostler, Peter, Blunn, Gordon W, Cannon, Stephen R, Briggs, Timothy WR
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051124/
https://www.ncbi.nlm.nih.gov/pubmed/21430872
http://dx.doi.org/10.4103/0019-5413.77137
_version_ 1782199445944795136
author Vijayan, Sridhar
Bartlett, William
Lee, Robert
Ostler, Peter
Blunn, Gordon W
Cannon, Stephen R
Briggs, Timothy WR
author_facet Vijayan, Sridhar
Bartlett, William
Lee, Robert
Ostler, Peter
Blunn, Gordon W
Cannon, Stephen R
Briggs, Timothy WR
author_sort Vijayan, Sridhar
collection PubMed
description BACKGROUND: Joint preservation is usually attempted in cases of bone tumors, though insufficient bone following tumour resection may prevent fixation of conventional joint sparing prosthesis. To preserve the hip joint in skeletally immature patients, we have combined autologous proximal femoral irradiation and intercalary re-implantation with custom made distal femoral replacements. MATERIALS AND METHODS: A retrospective cohort study of four patients (aged 4-12 years); in whom irradiated autologous bone was combined with an extendable distal femoral endoprostheses was performed. There were three cases of osteosarcoma and one case of Ewing’s sarcoma. RESULTS: At a mean follow-up of 70.5 months (range 26-185 months), all four patients were alive without evidence of local recurrence. There was no evidence of metastatic disease in three patients while one patient showed chest metastatic disease at presentation. In all cases, the irradiated segment of bone united with the proximal femur and demonstrated bone ongrowth at the prosthetic collar. There were no cases of loosening or peri-prosthetic fracture. One implant was revised after 14 years following fracture of the extending component of the endoprosthesis. CONCLUSIONS: We report encouraging results utilizing irradiated autologous proximal femoral bone combined with distal femoral replacement in skeletally immature patients.
format Text
id pubmed-3051124
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30511242011-03-22 Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery Vijayan, Sridhar Bartlett, William Lee, Robert Ostler, Peter Blunn, Gordon W Cannon, Stephen R Briggs, Timothy WR Indian J Orthop Original Article BACKGROUND: Joint preservation is usually attempted in cases of bone tumors, though insufficient bone following tumour resection may prevent fixation of conventional joint sparing prosthesis. To preserve the hip joint in skeletally immature patients, we have combined autologous proximal femoral irradiation and intercalary re-implantation with custom made distal femoral replacements. MATERIALS AND METHODS: A retrospective cohort study of four patients (aged 4-12 years); in whom irradiated autologous bone was combined with an extendable distal femoral endoprostheses was performed. There were three cases of osteosarcoma and one case of Ewing’s sarcoma. RESULTS: At a mean follow-up of 70.5 months (range 26-185 months), all four patients were alive without evidence of local recurrence. There was no evidence of metastatic disease in three patients while one patient showed chest metastatic disease at presentation. In all cases, the irradiated segment of bone united with the proximal femur and demonstrated bone ongrowth at the prosthetic collar. There were no cases of loosening or peri-prosthetic fracture. One implant was revised after 14 years following fracture of the extending component of the endoprosthesis. CONCLUSIONS: We report encouraging results utilizing irradiated autologous proximal femoral bone combined with distal femoral replacement in skeletally immature patients. Medknow Publications 2011 /pmc/articles/PMC3051124/ /pubmed/21430872 http://dx.doi.org/10.4103/0019-5413.77137 Text en © Indian Journal of Orthopaedics http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vijayan, Sridhar
Bartlett, William
Lee, Robert
Ostler, Peter
Blunn, Gordon W
Cannon, Stephen R
Briggs, Timothy WR
Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title_full Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title_fullStr Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title_full_unstemmed Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title_short Use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
title_sort use of irradiated autologous bone in joint sparing endoprosthetic femoral replacement tumor surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051124/
https://www.ncbi.nlm.nih.gov/pubmed/21430872
http://dx.doi.org/10.4103/0019-5413.77137
work_keys_str_mv AT vijayansridhar useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT bartlettwilliam useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT leerobert useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT ostlerpeter useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT blunngordonw useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT cannonstephenr useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery
AT briggstimothywr useofirradiatedautologousboneinjointsparingendoprostheticfemoralreplacementtumorsurgery